Select your country or region
- Africa
- America
- Asia
- Europe
- Oceania
- Angola
- Cape Verde
- Egypt
- Guinea-Bissau
- Mozambique
- São Tomé and Príncipe
- Australia
- New Zealand
- Bahrain
- Bangladesh
- Brunei
- Cambodia
- China
- Dubai (United Arab Emirates)
- Hong Kong SAR
- India
- Indonesia
- Iraq
- Japan
- Jordan
- Kuwait
- Laos
- Lebanon
- Malaysia
- Oman
- Pakistan
- Philippines
- Qatar
- Saudi Arabia
- Singapore (Asia Pacific)
- South Korea
- Sri Lanka
- Taiwan, China
- Thailand
- Vietnam
- Yemen
- Andorra
- Austria
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Gibraltar
- Iceland
- Ireland
- Italy
- Norway
- Poland
- Portugal
- San Marino
- Slovak Republic
- Spain
- Spain (Headquarters)
- Sweden
- Switzerland
- United Kingdom
- Vaticano
- Argentina
- Aruba
- Bolivia
- Brazil
- Canada
- Chile
- Colombia
- Costa Rica
- Curacao
- Dominican Republic
- Ecuador
- El Salvador
- Guatemala
- Honduras
- Mexico
- Nicaragua
- Panama
- Paraguay
- Peru
- Surinam
- Trinidad and Tobago
- USA
- Uruguay
- Venezuela
Grifols Australia PTY Ltd
Grifols Australia was established in 1990. Based in Melbourne, we cover the Australian and New Zealand markets. Our state-of-the art of Blood Typing reagents manufacturing facility is also based in our site in Melbourne.
We offer a comprehensive portfolio of products and services from the Bioscience, Diagnostic, Hospital, and Bio Supplies divisions. Safety and quality are our top priorities as we deliver on our mission to improve the health and well-being of people around the world.
Grifols Australia
Unit 5 / 80 Fairbank Road
Clayton South
Victoria 3169
AUSTRALIA
Contact information:
Tel: +61 3 95359333
Fax: +61 3 95359300
Mail:
australia_info@grifols.com
australia_medinfo@grifols.com
Notification of adverse reactions
To report an adverse drug reaction click here
Contact with Grifols
Certificate and ISO policy
Grifols Australia Pty Ltd is a member of the Grifols global family of companies founded in 1909 by Josep Antoni Grifols i Lucas, a leader in plasma collection and a leading producer of plasma-derived biological medicines. Grifols Australia offers a comprehensive range of transfusion medicine, haemostasis, immunoassay and pharmacy validation solutions for clinical laboratories, blood banks and hospitals. Grifols Australia maintains certification to the Therapeutic Goods (Medical Devices) Regulations 2002 and ISO 13485:2016 issued by the Therapeutic Goods Administration to develop, manufacture, and distribute in-vitro diagnostic products. Grifols Australia is committed to quality, safety, and innovation to meet the demands of patient safety and represent the pioneering spirit of the global organization.